Literature DB >> 10200872

Lack of ritonavir antifungal effect in vitro.

P Diz, A Ocampo, I Iglesias, I Otero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10200872      PMCID： PMC89250     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes?

Authors:  F C Odds
Journal:  Rev Iberoam Micol       Date:  1997-09       Impact factor: 1.044

2.  Reduction in oropharyngeal candidiasis following introduction of protease inhibitors.

Authors:  S Hood; A Bonington; J Evans; D Denning
Journal:  AIDS       Date:  1998-03-05       Impact factor: 4.177

3.  Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy.

Authors:  H Valdez; B M Gripshover; R A Salata; M M Lederman
Journal:  AIDS       Date:  1998-03-26       Impact factor: 4.177

4.  Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir.

Authors:  B S Zingman
Journal:  N Engl J Med       Date:  1996-06-20       Impact factor: 91.245

Review 5.  Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease.

Authors:  J S Greenspan
Journal:  Oral Dis       Date:  1997-05       Impact factor: 3.511

6.  Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro.

Authors:  A Gruber; E Lukasser-Vogl; M Borg-von Zepelin; M P Dierich; R Würzner
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

7.  Risk factors and physiopathology of candidiasis.

Authors:  J M Senet
Journal:  Rev Iberoam Micol       Date:  1997-03       Impact factor: 1.044

Review 8.  The role of Candida albicans secreted aspartic proteinase in the development of candidoses.

Authors:  L Hoegl; M Ollert; H C Korting
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

9.  Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.

Authors:  F De Bernardis; P Chiani; M Ciccozzi; G Pellegrini; T Ceddia; G D'Offizzi; I Quinti; P A Sullivan; A Cassone
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441
  9 in total
  1 in total

Review 1.  Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.

Authors:  Julian R Naglik; Stephen J Challacombe; Bernhard Hube
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.